Skip to content

Public FDA record

Z-2114-2018: Bivona Tracheostomy Tube Tracheostomy Tubes

Recall record Z-2114-2018 for Smiths Medical ASD Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2114-2018
Company in FDA record
Smiths Medical ASD Inc.
FDA record creation date
Jun 7, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Carton labeling is printed with "Sterile" indicated labeling, however the device is not sold as sterile.

Source facts

Action
Customers were notified via letter on approximately 04/02/2018. Instructions included to determine if there are any affected Customized Bivona Tracheostomy Tubes in inventory, notify customers if the devices have been further distributed, arrange for the return of affected devices, and complete and return the acknowledgement response form.
Initiated
2018-04-02
Root cause
Error in labeling
Terminated
2018-11-14
Distribution
Domestic distribution to CA, FL, GA, ID, NJ, NM, OH, VA. International distribution to France.
Recall number
Z-2114-2018
Recall status
Terminated
CDRH record ID
164546
FDA record created
2018-06-07
Recall event number
80092

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗